WallStreetZenWallStreetZen

NASDAQ: PRTA
Prothena Corp Public Ltd Co Stock

$36.08-1.72 (-4.55%)
Updated Dec 8, 2023
PRTA Price
$36.08
Fair Value Price
$49.15
Market Cap
$1.94B
52 Week Low
$28.51
52 Week High
$79.65
P/E
-26.73x
P/B
3.14x
P/S
18.33x
PEG
N/A
Dividend Yield
N/A
Revenue
$140.98M
Earnings
-$73.20M
Gross Margin
100%
Operating Margin
-61.37%
Profit Margin
-51.9%
Debt to Equity
0.21
Operating Cash Flow
-$88M
Beta
1.3
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PRTA Overview

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease; PRX004 that completed Phase I clinical trial for the treatment of Transthyretin amyloidosis; and PRX005, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its discovery and preclinical programs include PRX012 for the treatment of Alzheimer's disease; and dual Aß-Tau vaccine for the treatment and prevention of Alzheimer's disease. Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. The company was founded in 2012 and is based in Dublin, Ireland.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PRTA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PRTA ($36.08) is undervalued by 26.59% relative to our estimate of its Fair Value price of $49.15 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PRTA ($36.08) is significantly undervalued by 26.59% relative to our estimate of its Fair Value price of $49.15 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
PRTA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PRTA due diligence checks available for Premium users.

Be the first to know about important PRTA news, forecast changes, insider trades & much more!

PRTA News

Valuation

PRTA fair value

Fair Value of PRTA stock based on Discounted Cash Flow (DCF)
Price
$36.08
Fair Value
$49.15
Undervalued by
26.59%
PRTA ($36.08) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PRTA ($36.08) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PRTA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PRTA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-26.73x
Industry
11.7x
Market
31.32x

PRTA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.14x
Industry
5.42x
PRTA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PRTA's financial health

Profit margin

Revenue
$84.9M
Net Income
$21.9M
Profit Margin
25.8%
PRTA's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
PRTA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$746.9M
Liabilities
$129.7M
Debt to equity
0.21
PRTA's short-term assets ($690.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRTA's short-term assets ($690.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRTA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PRTA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$9.5M
Investing
-$442.0k
Financing
$2.7M
PRTA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PRTA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
PRTA$1.94B-4.55%-26.73x3.14x
NMRA$1.92B+0.80%N/A3.75x
SWTX$1.97B+3.28%-6.47x4.99x
IDYA$1.99B-1.18%-15.52x3.92x
PTCT$1.99B+0.42%-3.05x-2.97x

Prothena Public Co Stock FAQ

What is Prothena Public Co's quote symbol?

(NASDAQ: PRTA) Prothena Public Co trades on the NASDAQ under the ticker symbol PRTA. Prothena Public Co stock quotes can also be displayed as NASDAQ: PRTA.

If you're new to stock investing, here's how to buy Prothena Public Co stock.

What is the 52 week high and low for Prothena Public Co (NASDAQ: PRTA)?

(NASDAQ: PRTA) Prothena Public Co's 52-week high was $79.65, and its 52-week low was $28.51. It is currently -54.7% from its 52-week high and 26.55% from its 52-week low.

How much is Prothena Public Co stock worth today?

(NASDAQ: PRTA) Prothena Public Co currently has 53,665,349 outstanding shares. With Prothena Public Co stock trading at $36.08 per share, the total value of Prothena Public Co stock (market capitalization) is $1.94B.

Prothena Public Co stock was originally listed at a price of $7.20 in Dec 21, 2012. If you had invested in Prothena Public Co stock at $7.20, your return over the last 10 years would have been 401.11%, for an annualized return of 17.49% (not including any dividends or dividend reinvestments).

How much is Prothena Public Co's stock price per share?

(NASDAQ: PRTA) Prothena Public Co stock price per share is $36.08 today (as of Dec 8, 2023).

What is Prothena Public Co's Market Cap?

(NASDAQ: PRTA) Prothena Public Co's market cap is $1.94B, as of Dec 10, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Prothena Public Co's market cap is calculated by multiplying PRTA's current stock price of $36.08 by PRTA's total outstanding shares of 53,665,349.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.